These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1940199)

  • 1. Gastroduodenal injury and repair mechanisms.
    Hagen SJ
    Curr Opin Gastroenterol; 2024 Jun; ():. PubMed ID: 38935320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of endogenous prostaglandins in gastric secretion and mucosal defense.
    Cohen MM
    Clin Invest Med; 1987 May; 10(3):226-31. PubMed ID: 3040310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic mapping of metabolic traits in the blind Mexican cavefish reveals sex-dependent quantitative trait loci associated with cave adaptation.
    Riddle MR; Aspiras A; Damen F; McGaugh S; Tabin JA; Tabin CJ
    BMC Ecol Evol; 2021 May; 21(1):94. PubMed ID: 34020589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment Mechanism of
    Zhang X; Wang Y; Li X; Dai Y; Wang Q; Wang G; Liu D; Gu X; Yu D; Ma Y; Zhang C
    Front Pharmacol; 2019; 10():750. PubMed ID: 31333466
    [No Abstract]   [Full Text] [Related]  

  • 5. Development of multitarget agents possessing soluble epoxide hydrolase inhibitory activity.
    Hiesinger K; Wagner KM; Hammock BD; Proschak E; Hwang SH
    Prostaglandins Other Lipid Mediat; 2019 Feb; 140():31-39. PubMed ID: 30593866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Vagotomy and Decreased Risk of Subsequent Ischemic Stroke in Complicated Peptic Ulcer Patients: an Asian Population Study.
    Fang CW; Tseng CH; Wu SC; Chen WT; Muo CH
    World J Surg; 2017 Dec; 41(12):3171-3179. PubMed ID: 28726018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent multitarget FAAH-COX inhibitors: Design and structure-activity relationship studies.
    Migliore M; Habrant D; Sasso O; Albani C; Bertozzi SM; Armirotti A; Piomelli D; Scarpelli R
    Eur J Med Chem; 2016 Feb; 109():216-37. PubMed ID: 26774927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Double Whammy: Targeting Both Fatty Acid Amide Hydrolase (FAAH) and Cyclooxygenase (COX) To Treat Pain and Inflammation.
    Scarpelli R; Sasso O; Piomelli D
    ChemMedChem; 2016 Jun; 11(12):1242-51. PubMed ID: 26486424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ganoderma lucidum Pharmacopuncture for the Treatment of Acute Gastric Ulcers in Rats.
    Park JH; Jang KJ; Kim CH; Lee YH; Lee SJ; Kim BH; Yoon HM
    J Pharmacopuncture; 2014 Sep; 17(3):40-9. PubMed ID: 25780708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multitarget fatty acid amide hydrolase/cyclooxygenase blockade suppresses intestinal inflammation and protects against nonsteroidal anti-inflammatory drug-dependent gastrointestinal damage.
    Sasso O; Migliore M; Habrant D; Armirotti A; Albani C; Summa M; Moreno-Sanz G; Scarpelli R; Piomelli D
    FASEB J; 2015 Jun; 29(6):2616-27. PubMed ID: 25757568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lower serum level of adiponectin is associated with increased risk of endoscopic erosive gastritis.
    Yamamoto S; Watabe K; Tsutsui S; Kiso S; Hamasaki T; Kato M; Kamada Y; Yoshida Y; Kihara S; Umeda M; Furubayashi A; Kinoshita K; Kishida O; Fujimoto T; Yamada A; Tsukamoto Y; Hayashi N; Matsuzawa Y
    Dig Dis Sci; 2011 Aug; 56(8):2354-60. PubMed ID: 21448696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenosine: an immune modulator of inflammatory bowel diseases.
    Ye JH; Rajendran VM
    World J Gastroenterol; 2009 Sep; 15(36):4491-8. PubMed ID: 19777607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk management profile of etoricoxib: an example of personalized medicine.
    Patrignani P; Tacconelli S; Capone ML
    Ther Clin Risk Manag; 2008 Oct; 4(5):983-97. PubMed ID: 19209280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of prostaglandins in gastroduodenal mucosal protection.
    Wilson DE
    J Clin Gastroenterol; 1991; 13 Suppl 1():S65-71. PubMed ID: 1940199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mucosal defense and repair. Role of prostaglandins in the stomach and duodenum.
    Cryer B
    Gastroenterol Clin North Am; 2001 Dec; 30(4):877-94, v-vi. PubMed ID: 11764533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of gastric and duodenal damage and protection.
    Hudson N; Hawthorne AB; Cole AT; Jones PD; Hawkey CJ
    Hepatogastroenterology; 1992 Feb; 39 Suppl 1():31-6. PubMed ID: 1577394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonsteroidal anti-inflammatory drugs: how do they damage gastroduodenal mucosa?
    Scarpignato C
    Dig Dis; 1995 Jan; 13 Suppl 1():9-39. PubMed ID: 7697906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effects of prostaglandins against nonsteroidal anti-inflammatory drug-induced gastrointestinal mucosal injury.
    Dajani EZ; Agrawal NM
    Int J Clin Pharmacol Res; 1989; 9(6):359-69. PubMed ID: 2699464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prostaglandins: mucosal protection and peptic ulceration.
    Hawkey CJ
    Methods Find Exp Clin Pharmacol; 1989; 11 Suppl 1():45-51. PubMed ID: 2657288
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.